ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,749Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 315

$383K Total Retail Price of All Prescriptions

Rank: 115 out of 315

354 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 354 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 5,949 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
SIMVASTATIN 407 348 1 1
LOSARTAN POTASSIUM 341 305 2 4
LISINOPRIL 316 290 3 3
LEVOTHYROXINE SODIUM 283 241 4 6
AMLODIPINE BESYLATE 212 200 5 2
OMEPRAZOLE 200 166 6 9
ATORVASTATIN CALCIUM 200 191 6 5
PRAVASTATIN SODIUM 188 172 8 10
METOPROLOL SUCCINATE 180 154 9 13
METFORMIN HCL 160 144 10 7
METOPROLOL TARTRATE 147 140 11 18
FENOFIBRATE 141 127 12 43
LOVASTATIN 140 126 13 8
MELOXICAM 134 121 14 77
LOSARTAN-HYDROCHLOROTHIAZIDE 126 126 15 17
DONEPEZIL HCL 99 99 16 28
ALENDRONATE SODIUM 91 91 17 12
FUROSEMIDE 84 70 18 15
PREDNISONE 84 68 18 41
TERAZOSIN HCL 83 75 20 63
CARVEDILOL 82 73 21 22
HYDROCODONE-ACETAMINOPHEN 81 59 S3 22 19
JANUVIA 81 64 22 31
ALLOPURINOL 75 70 24 14
FELODIPINE ER 75 74 24 23
SERTRALINE HCL 73 73 26 100
WARFARIN SODIUM 70 59 27 20
SPIRONOLACTONE 70 66 27 95
GLYBURIDE 68 60 R 29 49
NAMENDA 66 66 30 38
AZITHROMYCIN 65 53 31 39
TAMSULOSIN HCL 63 62 32 21
CIPROFLOXACIN HCL 60 57 33 58
ZOLPIDEM TARTRATE 59 54 34 29
GABAPENTIN 57 52 35 37
TRIAMCINOLONE ACETONIDE 56 49 36 62
CLOPIDOGREL 54 47 37 25
CEFDINIR 53 45 38 195
PLAVIX 52 50 39 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.